{
  "paper_id": "PMC11571512",
  "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11571512/",
  "figures": {
    "figure_1": {
      "figure_number": "Figure 1",
      "title": "Fig. 1.",
      "caption": "Journal article reporting standards flowchart. tDCS, transcranial direct current stimulation. rTMS, repetitive transcranial magnetic stimulation",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a712/11571512/426ddb1ac45c/12916_2024_3751_Fig1_HTML.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a712/11571512/426ddb1ac45c/12916_2024_3751_Fig1_HTML.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a712/11571512/426ddb1ac45c/12916_2024_3751_Fig1_HTML.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a712/11571512/426ddb1ac45c/12916_2024_3751_Fig1_HTML.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "Fig1",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a712/11571512/426ddb1ac45c/12916_2024_3751_Fig1_HTML.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC11571512/images/figure_1.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a712/11571512/426ddb1ac45c/12916_2024_3751_Fig1_HTML.jpg"
    }
  },
  "claims": [
    {
      "sentence": "G*Power software was used to calculate the sample size, and the minimum sample size was 141.Randomisation to treatment and blinding\nThe CONSORT chart for this clinical trial is shown in Fig. 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "At the end of the 4-week intervention period, the retention rate was 95.7% (157/164) (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "At baseline, there were no significant differences among the three groups all aspects, including demographic and clinical information (Table 1).Primary outcomes\nBased on the analysis of the total PSQI score and sex grouping, the results showed a significant difference in the total PSQI score among the three groups of males at 2 weeks, 4 weeks, and 3 months after treatment (p < 0.05), and the tDCS + rTMS group had the lowest PSQI total score (Fig. 2A, B).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "PSQI, Pittsburgh Sleep Quality IndexBased on the analysis of total PSQI score and age groups (Fig. 2C, D), the results showed that there were significant differences in total PSQI score among those aged 18–50 years at 2 weeks, 4 weeks, and 3 months after treatment (p < 0.05), with the tDCS + rTMS group having the lowest total PSQI score.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel C",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Further two-by-two comparisons (Fig. 3) showed that at 2 weeks of treatment, the post-treatment scores of total PSQI score, sleep quality, sleep duration, and sleep efficiency in the tDCS + rTMS group were significantly lower than those in the tDCS + sham rTMS group (p < 0.05).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Significant results are highlighted (p < 0.05) in bold\nThe data are presented as mean ± standard deviation (SD)\nFig. 3.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Significant results are highlighted (p < 0.05) in boldSecondary outcomes\nLongitudinal changes in anxiety and depression severity over 4 weeks in the three groups were revealed by the total score and scores for each factor of the HAMA and HAMD, as shown in Fig. 4.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "G*Power software was used to calculate the sample size, and the minimum sample size was 141.Randomisation to treatment and blinding\nThe CONSORT chart for this clinical trial is shown in Fig. 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "At the end of the 4-week intervention period, the retention rate was 95.7% (157/164) (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "At baseline, there were no significant differences among the three groups all aspects, including demographic and clinical information (Table 1).Primary outcomes\nBased on the analysis of the total PSQI score and sex grouping, the results showed a significant difference in the total PSQI score among the three groups of males at 2 weeks, 4 weeks, and 3 months after treatment (p < 0.05), and the tDCS + rTMS group had the lowest PSQI total score (Fig. 2A, B).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "PSQI, Pittsburgh Sleep Quality IndexBased on the analysis of total PSQI score and age groups (Fig. 2C, D), the results showed that there were significant differences in total PSQI score among those aged 18–50 years at 2 weeks, 4 weeks, and 3 months after treatment (p < 0.05), with the tDCS + rTMS group having the lowest total PSQI score.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel C",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Further two-by-two comparisons (Fig. 3) showed that at 2 weeks of treatment, the post-treatment scores of total PSQI score, sleep quality, sleep duration, and sleep efficiency in the tDCS + rTMS group were significantly lower than those in the tDCS + sham rTMS group (p < 0.05).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Significant results are highlighted (p < 0.05) in bold\nThe data are presented as mean ± standard deviation (SD)\nFig. 3.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Significant results are highlighted (p < 0.05) in boldSecondary outcomes\nLongitudinal changes in anxiety and depression severity over 4 weeks in the three groups were revealed by the total score and scores for each factor of the HAMA and HAMD, as shown in Fig. 4.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "G*Power software was used to calculate the sample size, and the minimum sample size was 141.Randomisation to treatment and blinding\nThe CONSORT chart for this clinical trial is shown in Fig. 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "At the end of the 4-week intervention period, the retention rate was 95.7% (157/164) (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "At baseline, there were no significant differences among the three groups all aspects, including demographic and clinical information (Table 1).Primary outcomes\nBased on the analysis of the total PSQI score and sex grouping, the results showed a significant difference in the total PSQI score among the three groups of males at 2 weeks, 4 weeks, and 3 months after treatment (p < 0.05), and the tDCS + rTMS group had the lowest PSQI total score (Fig. 2A, B).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "PSQI, Pittsburgh Sleep Quality IndexBased on the analysis of total PSQI score and age groups (Fig. 2C, D), the results showed that there were significant differences in total PSQI score among those aged 18–50 years at 2 weeks, 4 weeks, and 3 months after treatment (p < 0.05), with the tDCS + rTMS group having the lowest total PSQI score.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel C",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Further two-by-two comparisons (Fig. 3) showed that at 2 weeks of treatment, the post-treatment scores of total PSQI score, sleep quality, sleep duration, and sleep efficiency in the tDCS + rTMS group were significantly lower than those in the tDCS + sham rTMS group (p < 0.05).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Significant results are highlighted (p < 0.05) in bold\nThe data are presented as mean ± standard deviation (SD)\nFig. 3.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Significant results are highlighted (p < 0.05) in boldSecondary outcomes\nLongitudinal changes in anxiety and depression severity over 4 weeks in the three groups were revealed by the total score and scores for each factor of the HAMA and HAMD, as shown in Fig. 4.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "G*Power software was used to calculate the sample size, and the minimum sample size was 141.Randomisation to treatment and blinding\nThe CONSORT chart for this clinical trial is shown in Fig. 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "At the end of the 4-week intervention period, the retention rate was 95.7% (157/164) (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "At baseline, there were no significant differences among the three groups all aspects, including demographic and clinical information (Table 1).Primary outcomes\nBased on the analysis of the total PSQI score and sex grouping, the results showed a significant difference in the total PSQI score among the three groups of males at 2 weeks, 4 weeks, and 3 months after treatment (p < 0.05), and the tDCS + rTMS group had the lowest PSQI total score (Fig. 2A, B).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "PSQI, Pittsburgh Sleep Quality IndexBased on the analysis of total PSQI score and age groups (Fig. 2C, D), the results showed that there were significant differences in total PSQI score among those aged 18–50 years at 2 weeks, 4 weeks, and 3 months after treatment (p < 0.05), with the tDCS + rTMS group having the lowest total PSQI score.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel C",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Further two-by-two comparisons (Fig. 3) showed that at 2 weeks of treatment, the post-treatment scores of total PSQI score, sleep quality, sleep duration, and sleep efficiency in the tDCS + rTMS group were significantly lower than those in the tDCS + sham rTMS group (p < 0.05).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Significant results are highlighted (p < 0.05) in bold\nThe data are presented as mean ± standard deviation (SD)\nFig. 3.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Significant results are highlighted (p < 0.05) in boldSecondary outcomes\nLongitudinal changes in anxiety and depression severity over 4 weeks in the three groups were revealed by the total score and scores for each factor of the HAMA and HAMD, as shown in Fig. 4.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "G*Power software was used to calculate the sample size, and the minimum sample size was 141.Randomisation to treatment and blinding\nThe CONSORT chart for this clinical trial is shown in Fig. 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "At the end of the 4-week intervention period, the retention rate was 95.7% (157/164) (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "At baseline, there were no significant differences among the three groups all aspects, including demographic and clinical information (Table 1).Primary outcomes\nBased on the analysis of the total PSQI score and sex grouping, the results showed a significant difference in the total PSQI score among the three groups of males at 2 weeks, 4 weeks, and 3 months after treatment (p < 0.05), and the tDCS + rTMS group had the lowest PSQI total score (Fig. 2A, B).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "PSQI, Pittsburgh Sleep Quality IndexBased on the analysis of total PSQI score and age groups (Fig. 2C, D), the results showed that there were significant differences in total PSQI score among those aged 18–50 years at 2 weeks, 4 weeks, and 3 months after treatment (p < 0.05), with the tDCS + rTMS group having the lowest total PSQI score.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel C",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Further two-by-two comparisons (Fig. 3) showed that at 2 weeks of treatment, the post-treatment scores of total PSQI score, sleep quality, sleep duration, and sleep efficiency in the tDCS + rTMS group were significantly lower than those in the tDCS + sham rTMS group (p < 0.05).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Significant results are highlighted (p < 0.05) in bold\nThe data are presented as mean ± standard deviation (SD)\nFig. 3.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Significant results are highlighted (p < 0.05) in boldSecondary outcomes\nLongitudinal changes in anxiety and depression severity over 4 weeks in the three groups were revealed by the total score and scores for each factor of the HAMA and HAMD, as shown in Fig. 4.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "G*Power software was used to calculate the sample size, and the minimum sample size was 141.Randomisation to treatment and blinding\nThe CONSORT chart for this clinical trial is shown in Fig. 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "At the end of the 4-week intervention period, the retention rate was 95.7% (157/164) (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "At baseline, there were no significant differences among the three groups all aspects, including demographic and clinical information (Table 1).Primary outcomes\nBased on the analysis of the total PSQI score and sex grouping, the results showed a significant difference in the total PSQI score among the three groups of males at 2 weeks, 4 weeks, and 3 months after treatment (p < 0.05), and the tDCS + rTMS group had the lowest PSQI total score (Fig. 2A, B).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "PSQI, Pittsburgh Sleep Quality IndexBased on the analysis of total PSQI score and age groups (Fig. 2C, D), the results showed that there were significant differences in total PSQI score among those aged 18–50 years at 2 weeks, 4 weeks, and 3 months after treatment (p < 0.05), with the tDCS + rTMS group having the lowest total PSQI score.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel C",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Further two-by-two comparisons (Fig. 3) showed that at 2 weeks of treatment, the post-treatment scores of total PSQI score, sleep quality, sleep duration, and sleep efficiency in the tDCS + rTMS group were significantly lower than those in the tDCS + sham rTMS group (p < 0.05).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Significant results are highlighted (p < 0.05) in bold\nThe data are presented as mean ± standard deviation (SD)\nFig. 3.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Significant results are highlighted (p < 0.05) in boldSecondary outcomes\nLongitudinal changes in anxiety and depression severity over 4 weeks in the three groups were revealed by the total score and scores for each factor of the HAMA and HAMD, as shown in Fig. 4.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "G*Power software was used to calculate the sample size, and the minimum sample size was 141.Randomisation to treatment and blinding\nThe CONSORT chart for this clinical trial is shown in Fig. 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "At the end of the 4-week intervention period, the retention rate was 95.7% (157/164) (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "At baseline, there were no significant differences among the three groups all aspects, including demographic and clinical information (Table 1).Primary outcomes\nBased on the analysis of the total PSQI score and sex grouping, the results showed a significant difference in the total PSQI score among the three groups of males at 2 weeks, 4 weeks, and 3 months after treatment (p < 0.05), and the tDCS + rTMS group had the lowest PSQI total score (Fig. 2A, B).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "PSQI, Pittsburgh Sleep Quality IndexBased on the analysis of total PSQI score and age groups (Fig. 2C, D), the results showed that there were significant differences in total PSQI score among those aged 18–50 years at 2 weeks, 4 weeks, and 3 months after treatment (p < 0.05), with the tDCS + rTMS group having the lowest total PSQI score.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel C",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Further two-by-two comparisons (Fig. 3) showed that at 2 weeks of treatment, the post-treatment scores of total PSQI score, sleep quality, sleep duration, and sleep efficiency in the tDCS + rTMS group were significantly lower than those in the tDCS + sham rTMS group (p < 0.05).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Significant results are highlighted (p < 0.05) in bold\nThe data are presented as mean ± standard deviation (SD)\nFig. 3.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Significant results are highlighted (p < 0.05) in boldSecondary outcomes\nLongitudinal changes in anxiety and depression severity over 4 weeks in the three groups were revealed by the total score and scores for each factor of the HAMA and HAMD, as shown in Fig. 4.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "G*Power software was used to calculate the sample size, and the minimum sample size was 141.Randomisation to treatment and blinding\nThe CONSORT chart for this clinical trial is shown in Fig. 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "At the end of the 4-week intervention period, the retention rate was 95.7% (157/164) (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "At baseline, there were no significant differences among the three groups all aspects, including demographic and clinical information (Table 1).Primary outcomes\nBased on the analysis of the total PSQI score and sex grouping, the results showed a significant difference in the total PSQI score among the three groups of males at 2 weeks, 4 weeks, and 3 months after treatment (p < 0.05), and the tDCS + rTMS group had the lowest PSQI total score (Fig. 2A, B).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "PSQI, Pittsburgh Sleep Quality IndexBased on the analysis of total PSQI score and age groups (Fig. 2C, D), the results showed that there were significant differences in total PSQI score among those aged 18–50 years at 2 weeks, 4 weeks, and 3 months after treatment (p < 0.05), with the tDCS + rTMS group having the lowest total PSQI score.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel C",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Further two-by-two comparisons (Fig. 3) showed that at 2 weeks of treatment, the post-treatment scores of total PSQI score, sleep quality, sleep duration, and sleep efficiency in the tDCS + rTMS group were significantly lower than those in the tDCS + sham rTMS group (p < 0.05).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Significant results are highlighted (p < 0.05) in bold\nThe data are presented as mean ± standard deviation (SD)\nFig. 3.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Significant results are highlighted (p < 0.05) in boldSecondary outcomes\nLongitudinal changes in anxiety and depression severity over 4 weeks in the three groups were revealed by the total score and scores for each factor of the HAMA and HAMD, as shown in Fig. 4.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "G*Power software was used to calculate the sample size, and the minimum sample size was 141.Randomisation to treatment and blinding\nThe CONSORT chart for this clinical trial is shown in Fig. 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Randomisation to treatment and blinding\nThe CONSORT chart for this clinical trial is shown in Fig. 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "The CONSORT chart for this clinical trial is shown in Fig. 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "At the end of the 4-week intervention period, the retention rate was 95.7% (157/164) (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "At baseline, there were no significant differences among the three groups all aspects, including demographic and clinical information (Table 1).Primary outcomes\nBased on the analysis of the total PSQI score and sex grouping, the results showed a significant difference in the total PSQI score among the three groups of males at 2 weeks, 4 weeks, and 3 months after treatment (p < 0.05), and the tDCS + rTMS group had the lowest PSQI total score (Fig. 2A, B).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "PSQI, Pittsburgh Sleep Quality IndexBased on the analysis of total PSQI score and age groups (Fig. 2C, D), the results showed that there were significant differences in total PSQI score among those aged 18–50 years at 2 weeks, 4 weeks, and 3 months after treatment (p < 0.05), with the tDCS + rTMS group having the lowest total PSQI score.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel C",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Further two-by-two comparisons (Fig. 3) showed that at 2 weeks of treatment, the post-treatment scores of total PSQI score, sleep quality, sleep duration, and sleep efficiency in the tDCS + rTMS group were significantly lower than those in the tDCS + sham rTMS group (p < 0.05).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Significant results are highlighted (p < 0.05) in bold\nThe data are presented as mean ± standard deviation (SD)\nFig. 3.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Significant results are highlighted (p < 0.05) in boldSecondary outcomes\nLongitudinal changes in anxiety and depression severity over 4 weeks in the three groups were revealed by the total score and scores for each factor of the HAMA and HAMD, as shown in Fig. 4.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "At the end of the 4-week intervention period, the retention rate was 95.7% (157/164) (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "At the end of the 4-week intervention period, the retention rate was 95.7% (157/164) (Fig. 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Primary outcomes\nBased on the analysis of the total PSQI score and sex grouping, the results showed a significant difference in the total PSQI score among the three groups of males at 2 weeks, 4 weeks, and 3 months after treatment (p < 0.05), and the tDCS + rTMS group had the lowest PSQI total score (Fig. 2A, B).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "PSQI, Pittsburgh Sleep Quality IndexBased on the analysis of total PSQI score and age groups (Fig. 2C, D), the results showed that there were significant differences in total PSQI score among those aged 18–50 years at 2 weeks, 4 weeks, and 3 months after treatment (p < 0.05), with the tDCS + rTMS group having the lowest total PSQI score.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel C",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Further two-by-two comparisons (Fig. 3) showed that at 2 weeks of treatment, the post-treatment scores of total PSQI score, sleep quality, sleep duration, and sleep efficiency in the tDCS + rTMS group were significantly lower than those in the tDCS + sham rTMS group (p < 0.05).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Significant results are highlighted (p < 0.05) in bold\nThe data are presented as mean ± standard deviation (SD)\nFig. 3.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Based on the analysis of the total PSQI score and sex grouping, the results showed a significant difference in the total PSQI score among the three groups of males at 2 weeks, 4 weeks, and 3 months after treatment (p < 0.05), and the tDCS + rTMS group had the lowest PSQI total score (Fig. 2A, B).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel A",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Based on the analysis of total PSQI score and age groups (Fig. 2C, D), the results showed that there were significant differences in total PSQI score among those aged 18–50 years at 2 weeks, 4 weeks, and 3 months after treatment (p < 0.05), with the tDCS + rTMS group having the lowest total PSQI score.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "Panel C",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Further two-by-two comparisons (Fig. 3) showed that at 2 weeks of treatment, the post-treatment scores of total PSQI score, sleep quality, sleep duration, and sleep efficiency in the tDCS + rTMS group were significantly lower than those in the tDCS + sham rTMS group (p < 0.05).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Secondary outcomes\nLongitudinal changes in anxiety and depression severity over 4 weeks in the three groups were revealed by the total score and scores for each factor of the HAMA and HAMD, as shown in Fig. 4.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Longitudinal changes in anxiety and depression severity over 4 weeks in the three groups were revealed by the total score and scores for each factor of the HAMA and HAMD, as shown in Fig. 4.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    }
  ],
  "extraction_stats": {
    "figures_count": 1,
    "claims_count": 76,
    "images_downloaded": 1,
    "tables_filtered": 307
  }
}